Stockreport

BRIEF-Roche Says Satralizumab Added To Baseline Therapy Reduced Risk Of Relapse [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BRIEF-Roche Says Satralizumab Added To Baseline Therapy Reduced Risk Of Relapse | Reuters 1 Min Read Oct 15 (Reuters) - Roche Holding AG: * CHUGAI PRESENTS RESULTS FROM [Read more]